Rohini Chakravarthy, MD, MPH
Rohini Chakravarthy, MD, MPH
Assistant Professor of Pediatrics
Specialties
- Pediatric Hematology & Oncology (Pediatric Cancer)
Locations
- Chicago - Comer Children's Hospital
- About
- Specialties & Areas of Expertise
- Locations & Patient Information
- Education & Research
- Accepted Insurance
- External Professional Relationships
My name is Doctor Rohini Chakravarthy, and I am a pediatric bone marrow transplant doctor. This means I take care of patients with a variety of different diagnoses, such as cancer, sickle cell disease, and various immune disorders, guiding them through the transplant process. I love working at Comer because everyone here is deeply invested in taking care of our patients. From providing the necessary resources to getting creative when challenges arise, the team is committed to ensuring patients receive the care they need. This dedication to patient care is what I truly love about working here.
In addition to patient care, I focus much of my research on understanding the long-term effects of our therapies. My goal is to ensure we provide patients with the best evidence-based treatments available while minimizing the long-term complications of these therapies. When caring for a patient, my approach is to treat them as a whole person, not just their diagnosis. Mentors I’ve worked with during my training have taught me the importance of understanding what is most important to each patient—their needs, goals, and priorities. By tailoring treatment and care to these individual factors, I strive to not only help treat their disease but also ensure they have the best possible quality of life.
With expertise in stem cell transplant and cellular therapy, Dr. Chakravarthy focuses on the use of transplant and cellular therapies to treat malignant disorders. By integrating the latest research findings into her practice, she ensures that her patients receive the most effective, up-to-date, evidence-based treatments available.
In her approach to patient care, Dr. Chakravarthy emphasizes compassionate and individualized treatment plans. She believes that every patient has a unique story. By striving to build relationships, developing trust and open communication, her goal is to provide comprehensive care that addresses the physical, social and emotional symptoms that affects her young patients and their families. She hopes to ensure that each patient and family is supported through their journey.
Dr. Chakravarthy’s research focuses on long-term effects of cancer and transplant therapies with a particular interest in reproductive health and fertility. She hopes to continue to find innovate therapies that effective in curing disease but also have fewer long-term toxicities.
Areas of Expertise
- Pediatric Stem Cell Transplant
- Cellular Therapy
- Leukemia
- Lymphoma
- Solid Tumors in Children
Board Certifications
- Pediatrics
Languages Spoken
- English
- Tamil
Medical Education
- University of Kansas School of Medicine
Internship
- Medical College of Wisconsin Affiliated Hospitals/Childrens Wisconsin
Residency
- Medical College of Wisconsin Affiliated Hospitals/Children's Wisconsin
Fellowship
- Vanderbilt University Medical Center; University of Colorado/Childrens Hospital Colorado
News & Research
Insurance
- Aetna Better Health *see insurance page
- Aetna HMO (specialists only)
- Aetna Medicare Advantage HMO & PPO
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS Medicare Advantage HMO & PPO
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Choice HMO (specialists only)
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If you have questions regarding your insurance benefits at UChicago Medicine, please contact our financial counseling team at OPSFinancialCounseling@uchospitals.edu.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.